糖尿病合并高血压行硝苯地平联合厄贝沙坦治疗的疗效探讨.docVIP

糖尿病合并高血压行硝苯地平联合厄贝沙坦治疗的疗效探讨 　　[摘要] 目的 分析糖尿病合并高血压行硝苯地平联合厄贝沙坦治疗的效果。 方法 资料随机选自2013年9月―2014年9月该院收治的糖尿病合并高血压患者74例，随机分为两组，对照组37例予以硝苯地平治疗，研究组37例予以硝苯地平联合厄贝沙坦治疗，分析两组的临床疗效与血压、血糖改善情况。 结果 研究组的治疗总有效率明显高于对照组（P0.05）。两组血压、血糖均有所改善，且研究组的改善情况优于对照组（P0.05）。 结论 糖尿病合并高血压行硝苯地平联合厄贝沙坦治疗具有显著效果，可有效稳定血压与血糖水平。 　　[关键词] 糖尿病；高血压；硝苯地平；厄贝沙坦 　　[中图分类号] R544.1 [文献标识码] A [文章编号] 1674-0742（2015）02（a）-0116-02 　　Observation of the Curative Effect of Nifedipine Combined with Irbesartan in Diabetes Accompanying Hypertension 　　SUN Jing 　　Inner mongolia people’s hospital，Inner mongolia，Neimenggu 010052，China 　　[Abstract] Objective To analyze the curative effect of nifedipine combined with irbesartan in diabetes accompanying hypertension. Methods Data（74 cases） were randomly selected from the patients with diabetes accompanying hypertension who received treatment in our hospital from September2013 to September 2014. They were divided into two groups. 37 cases as the control group were given the nifedipine treatment； while the other 37 cases as the research group were given the nifedipine with irbesartan treatment. Then the clinical effect， the blood pressure and the blood sugar improvement in two groups were analyzed. Results The total effective rate of research group was apparently higher than that of control group（P 0.05）. Besides， both of the blood pressure and the blood sugar in two groups were improved， but the improvement in the research group was superior to that in the control group（P 0.05）. Conclusion Irbesartan combined with nifedipine in diabetes accompanying hypertension has significant effect and it can stabilize the levels of blood pressure and blood sugar. 　　[Key words] Diabetes； Hypertension； Nifedipine； Irbesartan 　　糖尿病合并高血压易致使心血管疾病的发生，从而增加患者致残率与致死率，因此加强患者的血糖、血压控制对提高患者生存质量具有重要意义[1]。该次选取2013年9月―2014年9月该院收治的74例糖尿病合并高血压患者，予以不同治疗方案并对比疗效，现报道如下。 　　1 资料与方法 　　1.1 一般资料 　　资料随机选自糖尿病合并高血压患者74例，糖尿病与高血压均符合临床诊断标准。随机分为对照组与研究组，两组各37例。对照组男女比例20：17，年龄37～75岁，平均（49.12±4.26）岁；研究组男女比例18：19，年龄35～73岁，平均（